Early diagnosis, personalised therapies and new targeted drugs are marking a paradigm shift for one of the cancers with the ...

The chemotherapy drip keeps its slow rhythm. Two bags hang on a metal stand beside Mary Ann Gwost Hennen’s chair, the fluid threading through a tube into the port in her chest. Every two weeks, Hennen ...

The trial at UT Southwestern Medical Center involves an innovative chemotherapy treatment for patients with locally advanced ...

UCLA researchers have developed a CAR-NKT cell therapy that has been more effective than current immunotherapies at fighting ...

A promising new targeted cancer therapy is now available to certain patients with advanced pancreatic cancer – from the comfort of their home. The treatment is available through a first-of-its-kind, ...

CINCINNATI (WKRC) — Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for those living with pancreatic cancer. This trial is ...

SAN DIEGO and CALGARY, AB, Feb. 19, 2025 /PRNewswire/ — Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, continues to ...

A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist ...

Mild dilatation of the main pancreatic duct, even without an obvious mass, is a risk factor for pancreatic cancer in ...

Please provide your email address to receive an email when new articles are posted on . In this video, Michael Cecchini, MD, discusses results of two clinical trials evaluating pamrevlumab in ...

D'Angelo's estate announced that it is launching the D’Angelo Pancreatic Cancer Fund in partnership with the Black Boy Joy ...

SAN FRANCISCO — Pancreatic cancer remains a highly fatal malignancy, and over the past three decades, improvement in survival has been modest. One of the reasons for the lack of new therapeutic agents ...